<unk>  is a competitive inhibitor of the enzyme HMG-CoA reductase, having a mechanism of action similar to that of other statins. Putative beneficial effects of<unk>  therapy on chronic heart failure may be negated by increases in collagen turnover markers as well as a reduction in plasma coenzyme Q10 levels in patients with chronic heart failure.
Rosuvastatin
Lovastatin
Atorvastatin
Clofibrate
Pravastatin
Fluvastatin
Fenofibrate
Simvastatin